Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis

BACKGROUND: Antiviral drugs have been recommended as prophylaxis for the reactivation of hepatitis B virus (HBV) infection in cancer patients undergoing chemotherapy. However, screening and antiviral prophylaxis for lung cancer remain controversial because of insufficient evidence. PURPOSE: In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu-tuan, Li, Xin, Liu, Zi-li, Xu, Zhou, Dai, Wei, Zhang, Ke, Wu, Jiu-song, Arshad, Bilal, Wu, Kai-nan, Kong, Ling-quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480953/
https://www.ncbi.nlm.nih.gov/pubmed/28640902
http://dx.doi.org/10.1371/journal.pone.0179680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480953/
https://www.ncbi.nlm.nih.gov/pubmed/28640902
http://dx.doi.org/10.1371/journal.pone.0179680

Ejemplares similares